A novel class of antibodies has been discovered that binds to a previously untargeted portion of the malaria parasite—a cryptic pGlu-CSP site on the Plasmodium falciparum (Pf) sporozoite surface. The ...

In 1967, Austrian–Brazilian immunologist Ruth Nussenzweig made a momentous discovery. By blasting malaria parasites with radiation, she could weaken them. When injected into mice, these feeble ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to a ...

Malaria remains a persistent public health burden, with Plasmodium falciparum causing the most dangerous form of malaria and the most lethal infections. Its capacity to develop resistance to current ...

With victims numbering in the millions, malaria is an infectious disease caused by the bite of a mosquito carrying the malaria parasite. After penetrating the skin, the pathogen moves with helical ...

A new malaria vaccine showed encouraging results in a phase 1 study conducted in Bamako, Mali, West Africa, a region where malaria remains a year-round threat to public health. Published in NEJM ...